Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

Abstract

ClinicalTrials.gov Identifier NCT00064428.

Keywords

MedicineFondaparinuxMyocardial infarctionHazard ratioPlaceboNumber needed to harmInternal medicineRandomized controlled trialHeparinAnesthesiaCardiologyConfidence intervalSurgeryRelative riskNumber needed to treatThrombosisVenous thromboembolism

Affiliated Institutions

Related Publications

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Gregg W. Stone , Bernhard Witzenbichler , Giulio Guagliumi +12 more

In patients with ST-segment elevation myocardial infarction who are undergoing primary PCI, anticoagulation with bivalirudin alone, as compared with heparin plus glycoprotein II...

2008 New England Journal of Medicine 1836 citations

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Philippe Gabríel Steg , Stefan James , Dan Atar +20 more

European Society of Cardiology (ESC) Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2012 European Heart Journal 6805 citations

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Håkan Emanuelsson , Claes Held , Jay Horrow +13 more

In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of de...

2009 New England Journal of Medicine 6927 citations

Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm

Jean‐Pierre Bassand

Over the last two decades, major improvements in clinical outcome have been achieved in the management of acute coronary syndromes (ACS), with or without ST-segment elevation. I...

2007 European Heart Journal 364 citations

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

Rupert Bauersachs , Scott D. Berkowitz , Benjamin Brenner +17 more

Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that may improve the benefit-to-risk profile of anticoagulation....

2010 New England Journal of Medicine 3179 citations

Publication Info

Year: 2006
Type: article
Volume: 295
Issue: 13
Pages: 1519-1530
Citations: 903
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

903

OpenAlex

Cite This

APA Style

                            
                                
                                    Shamir R. Mehta, 
                                
                                    Susan Chrolavicius, 
                                
                                    Rizwan Afzal
                                
                                et al.
                            
                            (2006). 
                            Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial. 
                            JAMA
                            , 295
                            (13)
                            , 1519-1530.
                            https://doi.org/10.1001/jama.295.13.joc60038
                        

Identifiers

DOI: 10.1001/jama.295.13.joc60038